MDN Pharmaceutics SRL
MDN Pharmaceutics reported total assets of 2,000 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Aug 2026).
The score of MDN Pharmaceutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MDN Pharmaceutics's annual accounts
| 2025 | |
|---|---|
| Net result | −1,127 € |
| Equity | 873 € |
| Cash | 647 € |
| EBITDA | −1,127 € |
| Total assets | 2,000 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Aug 2026
MDN Pharmaceutics's financial analysis
- Solvency43.7%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MDN Pharmaceutics
MDN Pharmaceutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1032.175.218
- VAT number
- BE1032175218
- Peppol
- Registered · 0208:1032175218 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Dec 2025
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 10 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
MDN Pharmaceutics (SRL) has been based in Brussels since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 1,127 € and equity of 873 €; its revenue is not published. Its solvency stands at 43.7%, above the median of its sector (37.8%).
Companies similar to MDN Pharmaceutics
Companies in the same business, of comparable size and area, outside its group.
- El Haibi Consulting Retail sale of pharmaceutical products Jette · balance sheet 19,014 €
- Destock Pharma Retail sale of pharmaceutical products Éghezée · balance sheet 608 €
- Fysiobelgium Retail sale of medical and orthopaedic goods Meerhout · balance sheet 6,081 €
- Serenity Pharma Retail sale of pharmaceutical products Silly · balance sheet 18,277 €
- AVICENNE Pharma Services Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 42,747 €
- Apharga Retail sale of pharmaceutical products Ferrières · balance sheet 23,536 €
- VitalisPharma Retail sale of pharmaceutical products Evere · balance sheet 45,436 €
- Verhuizen Anke BV Retail sale of pharmaceutical products Vorselaar · balance sheet 27,853 €
Frequently asked questions about MDN Pharmaceutics
What is the revenue of MDN Pharmaceutics?
MDN Pharmaceutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MDN Pharmaceutics?
In Belgium, the VAT number is the company number prefixed with BE: BE1032175218 for MDN Pharmaceutics, if the company is VAT-registered. Its company number (CBE) is 1032.175.218.
Where is the registered office of MDN Pharmaceutics?
According to the CBE register, the registered office of MDN Pharmaceutics is in 1000 Brussels.
What is the equity of MDN Pharmaceutics?
At the close of the 2025 financial year, the equity of MDN Pharmaceutics amounts to 873 €, a solvency of 43.7% of total assets.
Who manages MDN Pharmaceutics?
The register lists 1 active mandates at MDN Pharmaceutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MDN Pharmaceutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →